Lancet Neurology

The Lancet Neurology (commonly abbreviated as Lancet Neurol.) is the neurology specialty journal of The Lancet Publishing Group. Launched in May 2002 and published monthly, it reports a 2025 impact factor of 54.6 and ranks first among clinical neurology journals.The Lancet Neurology（常用缩写 Lancet Neurol.）是柳叶刀出版集团的神经病学专科期刊，2002 年 5 月创刊，为月刊，2025 年影响因子为 54.6，在临床神经病学期刊中排名第一。^[1]

Scope

• Scope: the journal publishes original research that advocates change in, or illuminates, neurological clinical practice, serving as an authoritative forum for key opinion leaders across medicine, government and health systems to influence practice, explore global policy and inform constructive change.学科定位： 发表倡导改变或阐明神经病学临床实践的原创研究，是医学、政府与卫生系统领域关键意见领袖影响临床实践、探讨全球政策的权威论坛。
• Topics: cerebrovascular disease, Alzheimer's disease and other dementias, epilepsy, migraine, neurological infections, movement disorders, multiple sclerosis, neuromuscular disorders, peripheral nerve disorders, paediatric neurology, sleep disorders and traumatic brain injury.收录主题： 脑血管病、阿尔茨海默病与其他痴呆、癫痫、偏头痛、神经系统感染、运动障碍、多发性硬化、神经肌肉疾病、周围神经病、儿科神经病学、睡眠障碍与创伤性脑损伤等。
• Article types: articles, reviews, rapid reviews, comments, correspondence, personal views, series and commissions, alongside editorials and a range of feature sections.文章体裁： 论文、综述、短综述、评论、通讯、个人观点、系列文章与委托报告，另设社论与各类特色栏目。
• Publishing model: hybrid, authors with open access funding may choose a gold or a green open access solution.出版模式： 混合出版，有开放获取经费的作者可选择 Gold OA 或绿色开放获取方案。^[1]
• Indexing and metrics: indexed by MEDLINE, PubMed, the SCIE and Scopus, the journal holds a 2025 impact factor of 54.6, first among 296 clinical neurology titles, with a CiteScore of 75.收录与指标： 被 MEDLINE、PubMed、SCIE 与 Scopus 等收录，2025 年影响因子 54.6，在 296 种临床神经病学期刊中居首，CiteScore 75。

History

• Founded: launched in May 2002 as the third monthly specialty review journal from The Lancet Publishing Group, following its oncology and infectious diseases titles.创刊： 2002 年 5 月创刊，是柳叶刀出版集团继肿瘤学与感染病学专科刊之后的第三种专科月刊。^[2]
• Content expansion: original research was added alongside reviews from 2005.内容扩展： 2005 年起在综述之外增设原创研究栏目。
• Publisher: published by The Lancet Group within Elsevier.出版方： 由 Elsevier 旗下的柳叶刀集团出版。
• Editorial transition: Elena Becker-Barroso has been editor-in-chief since July 2012, having joined as senior editor in 2005 and become deputy editor in 2008.主编更替： Elena Becker-Barroso 于 2012 年 7 月起任主编，2005 年入刊任高级编辑，2008 年任副主编。^[3]

Editors

• Editor-in-chief: Elena Becker-Barroso, PhD in molecular biology, with postdoctoral research on neurotrophin-mediated neuronal signalling.现任主编： Elena Becker-Barroso，分子生物学博士，曾从事神经营养因子介导的神经元信号转导研究。
• Other editors: deputy editor Laura Hart and senior editors Heather Brown, Morgane Boillot and Sarah Passey.其他编辑： 副主编 Laura Hart，高级编辑 Heather Brown、Morgane Boillot 与 Sarah Passey。
• Editorial board: alongside the in-house editors sits an international advisory board of some forty members from about fifteen countries, whose members have no formal involvement in content selection or peer review.编委构成： 编辑部之外设约 40 名的国际顾问委员会，覆盖约 15 国，委员不参与稿件遴选与评审。^[4]
• Submission and review: manuscripts are lodged through Editorial Manager and undergo external and statistical peer review, with a fast track offering publication in about ten weeks for qualifying papers.投稿与评审： 稿件经 Editorial Manager 系统递交，实行外部同行评审与统计评审，符合条件者可走快速通道约 10 周内发表。